Standout Papers

Nivolumab in patients with metastatic DNA m... 2006 2026 2012 2019 1.9k
  1. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study (2017)
    Michael J. Overman, Ray McDermott et al. The Lancet Oncology
  2. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial (2006)
    George D. Demetri, Allan T. van Oosterom et al. The Lancet
  3. Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib (2007)
    Tammy F. Chu, Maria A. Rupnick et al. The Lancet
  4. Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer (2011)
    Ben Tran, Scott Kopetz et al. Cancer
  5. Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer (2015)
    Scott Kopetz, Jayesh Desai et al. Journal of Clinical Oncology
  6. Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer (2015)
    Jeanne Tie, Isaac Kinde et al. Annals of Oncology
  7. Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study (2021)
    Josep Tabernero, Axel Grothey et al. Journal of Clinical Oncology
  8. Bispecific antibodies: advancing precision oncology (2024)
    Jayesh Desai, Elena Garralda et al. Trends in cancer
  9. Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial (2025)
    Scott Kopetz, Takayuki Yoshino et al. Nature Medicine

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 89 standout
Sub-graph 1 of 19

Citing Papers

Targeting KRAS in cancer
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout

Works of Jayesh Desai being referenced

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
2015 Standout
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer
2015 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Jayesh Desai 7478 4816 2326 3363 317 12.9k
Isabelle Ray‐Coquard 6720 4876 1700 2749 390 15.4k
Jeeyun Lee 7417 6559 2823 3348 502 14.0k
David P. Kelsen 8708 6226 1855 3084 290 14.4k
Antoîne Italiano 8717 8842 2167 3815 606 16.8k
Christine Chevreau 6054 9987 3788 6252 308 15.3k
Joon Oh Park 9002 7439 2818 4426 378 15.8k
Suzanne George 3579 6644 953 1759 255 11.4k
Kenichi Sugihara 10669 6611 1604 2593 499 17.2k
Maria Dêbiec‐Rychter 2629 7297 1067 2351 307 11.9k
Ian Chau 12763 6982 2318 2587 463 18.2k

All Works

Loading papers...

Rankless by CCL
2026